PT  - JOURNAL ARTICLE
AU  - Oranun Kerdpin
AU  - David J. Elliot
AU  - Peter I. Mackenzie
AU  - John O. Miners
TI  - Sulfinpyrazone <em>C-</em>Glucuronidation Is Catalyzed Selectively by Human UDP-Glucuronosyltransferase 1A9
AID  - 10.1124/dmd.106.012385
DP  - 2006 Dec 01
TA  - Drug Metabolism and Disposition
PG  - 1950--1953
VI  - 34
IP  - 12
4099  - http://dmd.aspetjournals.org/content/34/12/1950.short
4100  - http://dmd.aspetjournals.org/content/34/12/1950.full
SO  - Drug Metab Dispos2006 Dec 01; 34
AB  - The uricosuric agent sulfinpyrazone (SFZ) is metabolized via C-glucuronidation, an uncommon metabolic pathway, in humans. The present study aimed to characterize SFZ glucuronidation by human liver microsomes (HLMs) and identify the hepatic forms of UDP-glucuronosyltransferase responsible for this pathway. Incubations of SFZ with HLMs formed a single glucuronide that was resistant to β-glucuronidase and acid hydrolysis, consistent with formation of a C-glucuronide. Mass spectral analysis confirmed the identity of the metabolite as SFZ glucuronide (sulfinpyrazone β-d-glucuronide; SFZG). SFZ C-glucuronidation by HLMs exhibited Michaelis-Menten kinetics, with mean (±S.D.) Km and Vmax values of 51 ± 21 μM and 2.6 ± 0.6 pmol/min · mg, respectively. Fifteen recombinant human UDP-glucuronosyltransferases (UGTs), expressed in HEK293 cells, were screened for their capacity to catalyze SFZ C-glucuronidation. Of the hepatically expressed enzymes, only UGT1A9 formed SFZG. UGTs 1A7 and 1A10, which are expressed in the gastrointestinal tract, also metabolized SFZ, but rates of metabolism were low compared with UGT1A9. SFZ glucuronidation by UGT1A9 exhibited “weak” negative cooperative kinetics, which was modeled by the Hill equation (S50 16 μM). The data indicate that UGT1A9 is the enzyme responsible for hepatic SFZ C-glucuronidation and that SFZ may be used as a substrate “probe” for UGT1A9 activity in HLMs. The American Society for Pharmacology and Experimental Therapeutics